These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4821441)

  • 1. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 2. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 4. Dimethylheptyl-delta 6a-10a-tetrahydrocannabinol: effects after parenteral administration to man.
    Sidell FB; Pless JE; Neitlich H; Sussman P; Copelan HW; Sim VM
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):867-73. PubMed ID: 4571010
    [No Abstract]   [Full Text] [Related]  

  • 5. The in vitro and in vivo metabolism of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP).
    Lemberger L; McMahon RE; Archer RA; Matsumoto K; Rowe H
    J Pharmacol Exp Ther; 1973 Oct; 187(1):169-75. PubMed ID: 4746325
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.
    Perez-Reyes M; Timmons MC; Davis KH; Wall EM
    Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of marihuana in man.
    Clark SC; Greene C; Karr GW; MacCannell KL; Milstein SL
    Can J Physiol Pharmacol; 1974 Jun; 52(3):706-19. PubMed ID: 4850891
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical pharmacology of nabilone, a cannabinol derivative.
    Lemberger L; Rowe H
    Clin Pharmacol Ther; 1975 Dec; 18(6):720-6. PubMed ID: 1204278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME
    Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of orally administered delta-9-tetrahydrocannabinol in man.
    Hosko MJ; Kochar MS; Wang RI
    Clin Pharmacol Ther; 1973; 14(3):344-52. PubMed ID: 4698562
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans.
    Cooler P; Gregg JM
    South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
    Siemens AJ; Kalant H
    Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
    [No Abstract]   [Full Text] [Related]  

  • 19. Further evidence for a role of 2-phenylethylamine in the mode of action of delta 9-tetrahydrocannabinol.
    Sabelli HC; Pedemonte WA; Whalley C; Mosnaim AD; Vazquez AJ
    Life Sci; 1974 Jan; 14(1):149-56. PubMed ID: 4810493
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men.
    Tashkin DP; Shapiro BJ; Frank IM
    N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.